New Molecular Targets Are Reshaping Personalized Treatment of Low-Grade Non-Hodgkin Lymphoma
A new Research Topic in Frontiers in Hematology highlights epigenetic targets, immunotherapy combinations, resistance mechanisms, and prognostic models driving personalized ...
